Clinical pharmacology of midazolam in infants and children

Clinical Pharmacokinetics

Volumn 35, Issue 1, 1998, Pages 37-47

  Blumer, Jeffrey L ^a  

^a CASE WESTERN RESERVE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID; ALPHA HYDROXYMIDAZOLAM; BENZODIAZEPINE DERIVATIVE; CYTOCHROME P450; DIAZEPAM; LORAZEPAM; MIDAZOLAM;

ANTICONVULSANT ACTIVITY; APNEA; BLOOD BRAIN BARRIER; CHILD; DOSE TIME EFFECT RELATION; DRUG CLEARANCE; DRUG EXCRETION; DRUG HALF LIFE; DRUG METABOLISM; DRUG RECEPTOR BINDING; DRUG SOLUBILITY; HUMAN; HYPOTENSION; HYPOVENTILATION; INFANT; OXYGEN SATURATION; PH; PRIORITY JOURNAL; REVIEW; SEDATION; TRANQUILIZING ACTIVITY;

ANTI-ANXIETY AGENTS; CHILD; DRUG INTERACTIONS; DRUG TOLERANCE; EMERGENCY SERVICE, HOSPITAL; HUMANS; HYPNOTICS AND SEDATIVES; INFANT; INTENSIVE CARE UNITS; MIDAZOLAM;

EID: 0031875719     PISSN: 03125963     EISSN: None     Source Type: Journal    
DOI: 10.2165/00003088-199835010-00003     Document Type: Review

References (66)

1. Reves JG, Glass PS, Lubarsky DA. Nonbarbiturate intravenous anesthetics. In: Miller RD, editor. Anesthesia. 4th ed. New York: Churchill-Livingstone, 1994: 247-89
2. Zorumski CF, Isenberg KE. Insights into the structure and function of GABA-benzodiazepine receptors: ion channels and psychiatry. Am J Psychiatry 1991; 148: 162-73
3. Kehlet H. Surgical stress: the role of pain and analgesia. Br J Anaesth 1989; 63: 189-95
4. Kehlet H. The stress response to surgery: release mechanisms and the modifying effect of pain relief. Acta Chir Scand 1989; Suppl. 550: 22-8
5. Ryder W, Wright PA. Dental sedation: a review. Br Dent J 1988; 165: 207-16
6. Carrougher JG, Kadakia S, Shaffer RT, et al. Venous complications of midazolam versus diazepam. Gastrointest Endosc 1993; 39: 396-9
7. Ginsberg GG, Lewis JH, Gallagher JM, et al. Diazepam versus midazolam for colonoscopy: a prospective evaluation of predicted versus actual dosing requirements. Gastrointest Endosc 1992; 38: 651-6
8. Bianchi Porro G, Maroni S, Parente F, et al. Midazolam versus diazepam as premedication for upper gastrointestinal endoscopy: a randomized, double-blind, crossover study. Gastrointest Endosc 1988; 34: 252-4
9. Bardhan KD, Morris P, Taylor PC, et al. Intravenous sedation for upper gastrointestinal endoscopy: diazepam versus midazolam. BMJ 1984; 288: 1046
10. Lloyd-Thomas AR, Booker PD. Infusion of midazolam in paediatric patients after cardiac surgery. Br J Anaesth 1986; 58: 1109-15
11. Morselli PL, Principi N, Tognoni G, et al. Diazepam elimination in premature and full term infants, and children. J Perinat Med 1973; 1: 133-41
12. Kanto JH. Midazolam: the first water-soluble benzodiazepine. Pharmacology, pharmacokinetics, and efficacy in insomnia and anesthesia. Pharmacotherapy 1985; 5: 138-55
13. Reves JG, Fragen RL, Vinik R, et al. Midazolam: pharmacology and uses. Anesthesiology 1985; 62: 310-24
14. Booker PD, Beechey A, Lloyd-Thomas AR. Sedation for children requiring artificial ventilation using an infusion of midazolam. Br J Anaesth 1986; 58: 1104-8
15. Tolia V, Brennan S, Aravind MK, et al. Pharmacokinetic and pharmacodynamic study of midazolam in children during esophagogastroduodenoscopy. J Pediatr 1991; 119: 467-71
16. Hartwig S, Roth B, Theisohn M. Clinical experience with continuous intravenous sedation using midazolam and fentanyl in the pediatric intensive care unit. Eur J Pediatr 1991; 150: 784-8
17. Versed Product Information. Nutley, New Jersey: Roche Laboratories, 1997
18. McNabb AJ, Levine M, Glick N, et al. Midazolam following open heart surgery in children: haemodynamic effects of a loading dose. Paediatr Anaesth 1996; 6: 387-97
19. Kumar SP. Adverse drug reactions in the newborn. Ann Clin Lab Sci 1985; 15: 195-203
20. Baziel GM, Gimbriere JS, Booy LH. Benzodiazepine withdrawal reaction in two children following discontinuation of sedation with midazolam. Ann Pharmacother 1993; 27: 579-81
21. Bergman I, Steeves M, Buckart G, et al. Reversible neurologic abnormalities associated with prolonged intravenous midazolam and felanyl administration. J Pediatr 1991; 119: 644-9
22. Hughes J, Gill A, Leach HJ, et al. A prospective study of the adverse effects of midazolam on withdrawal in critically ill children. Acta Paediatr 1994; 83: 1194-99
23. Baziel GM, Gimbrere JS. Benzodiazepine withdrawal syndrome in two children following discontinuation of high dose midazolam [abstract]. Intensive Care Med 1990; 16: 5119
24. Garland DS, Dunne WM, Havens P et al. Peripheral intravenous catheter complications in critically ill children: a prospective study. Pediatrics 1992; 89: 1145-50
25. Brown WJK, Buist NR, Gipson HT, et al. Fatal benzyl alcohol poisoning in a neonatal intensive care unit [letter]. Lancet 1982; 1: 1250
26. Kumar SP. Adverse drug reactions in the newborn. Ann Clin Lab Sci 1985; 15: 195-203
27. Gershank J, Boecler B, Ensley H, et al. The gasping syndrome and benzyl alcohol poisoning. N Engl J Med 1982; 307: 1384-8
28. Kearns GL, Reed MD. Clinical pharmacokinetics in infants and children. A reappraisal. Clin Pharmacokinet 1989; 17 Suppl. 1: 29-67
29. Burtin P, Jacqz-Aigrain E, Girard P. Population pharmacokinetics of midazolam in neonates. Clin Pharmacol Ther 1994; 56: 615-25
30. Greenblatt DJ, Ehrenberg BL, Scavone JM, et al. Effect of infusion rate on the kinetic-dynamic relationship for intravenous midazolam [abstract]. Clin Pharmacol Ther 1993; 53: 218
31. Klotz U, Reimann IW. Chronopharmacokinetic study with prolonged infusion of midazolam. Clin Pharmacokinet 1984; 9: 469-74
32. Payne K, Matteyse FJ, Liebenberg D, et al. The pharmacokinetics of midazolam in paediatric patients. Eur J Clin Pharmacol 1989; 37: 267-72
33. Wandel C, Böcker R Bönrer H, et al. Midazolam is metabolized by at least three different cytochrome P450 enzymes. Br J Anesth 1944; 73: 658-61
34. Slaughter RL, Edwards DJ. Recent advances: the cytochrome P450 enzymes. Ann Pharmacother 1995; 29: 619-24
35. Schuetz JD, Beach DL, Guzelian PS. Selective expression of cytochrome P450 CYP3A mRNAs in embryonic and adult human liver. Pharmacogenetics 1994; 4: 11-20
36. Zeigler WH, Schalch E, Leishman B, et al. Comparison of the effects of intravenously administered miazolam, triazolam, and their hydroxy metabolites. Br J Clin Pharmacol 1983; Suppl. 1: 63S-69S
37. Paine MF, Shen DD, Kinze KL, et al. First-pass metabolism of midazolam by the human intestine. Clin Pharmacol Ther 1996; 60 (1): 14-24
38. Thummel KE, O'Shea D, Paine MF, et al. Oral first-pass elimination of midazolam involves both gastrointestinal and hepatic CYP3A-mediated metabolism. Clin Pharmacol Ther 1996; 59 (5): 491-502
39. Arendt RM, Greenblatt DJ, Liebisch DC, et al. Determinants of benzodiazepine brain uptake: lipophilicity versus binding affinity. Psychopharmacology 1987; 93: 72-6
40. Greenblatt DJ. Clinical pharmacokinetics of oxazepam and lorazepam. Clin Pharmacokinet 1981; 6: 88-105
41. Jones RD, Visram AR, Chan MM, et al. A comparison of three induction agents in paediatric anaesthesia cardiovascular effects and recovery. Anaesth Intensive Care 1994; 22: 545-55
42. Rey E, Delaunay L, Pons G, et al. Pharmacokinetics of midazolam in children: comparative study of intranasal and intravenous administration. Eur J Clin Pharmacol 1991; 41 (4): 355-7
43. Jacqz-Aigrain E, Wood C, Robieux I. Pharmacokinetics of midazolam in critically ill neonates. Eur J Clin Pharmacol 1990; 39 (2): 191-2
44. Jacqz-Aigrain E, Daoud P, Burtin P, et al. Pharmacokinetics of midazolam during continuous infusion in critically ill neonates. Eur J Clin Pharmacol 1992; 42 (3): 329-32
45. Hughes J, Gill AM, Mulhearn H, et al. Steady-state plasma concentrations of midazolam in critically ill infants and children. Ann Pharmacother 1996; 30: 27-30
46. Patel IH, Soni PP, Fukuda EK, et al. The pharmacokinetics of midazolam in patients with congestive heart failure. Br J Clin Pharmacol 1990; 29: 565-9
47. Pentikainen PJ, Valisalmi L, Himberg JJ, et al. Pharmacokinetics of midazolam following intravenous and oral administration in patients with chronic liver disease and in healthy subjects. J Clin Pharmacol 1989; 29: 272-7
48. Trouvin JH, Farinotti R, Haberer JP, et al. Pharmacokinetics of midazolam in anaesthetised cirrhotic patients. Br J Anaesth 1988; 60: 762-7
49. Driessen JJ, Vree TB, Guelen PJM. The effects of acute changes in renal function on the pharmacokinetics of midazolam during long-term infusion in ICU patients. Acta Anaesthesiol Belg 1991; 42: 149-55
50. Jacqz-Aigrain E, Daoud P, Burtin P, et al. Placebo-controlled trial of midazolam sedation in mechanically ventilated newborn babies. Lancet 1994; 344: 646-50
51. Allonen H, Ziegler G, Klotz U. Midazolam kinetics. Clin Pharmacol Ther 1981; 30: 653-61
52. Olkkola KT, Aranko K, Luurila H, et al. A potentially hazardous interaction between erythromycin and midazolam. Clin Pharmacol Ther 1993; 53: 298-305
53. Backman JT, Olkkola KT, Aranko K, et al. Dose of midazolam should be reduced during diltiazem and verapamil tretments. Br J Clin Pharmacol 1994; 37: 221-5
54. Klotz U, Ziegler G, Ludwig L, et al. Pharmacodynamic interaction between midazolam and a specific benzodiazepine antagonist in humans. J Clin Pharmacol 1985; 25: 400-6
55. Shannon M, Albers G, Burkhart K. Safety and efficacy of flumazenil in the reversal of benzodiazepine-induced conscious sedation. The flumazenil pediatric study group. J Pediatr 1997; 131: 582-6
56. Hickey PR, Wessel DL, Streitz SL, et al. Transcatheter closure of atrial septal defects: hemodynamic complications and anesthetic management. Anesth Analg 1992; 74: 44-50
57. Tolia V, Fleming SL, Kauffman RE. Randomized, double-blind trial of midazolam and diazepam for endoscopic sedation in children. Dev Pharmacol Ther 1990; 14: 141-7
58. Bahal-O'Mara N, Nahata MC, Murray RD, et al. Sedation with meperidine and midazolam in pediatric patients undergoing endoscopy. Eur J Clin Pharmacol 1994; 47: 319-23
59. Sandler ES, Weyman C, Conner K, et al. Midazolam versus fentanyl as premedication for painful procedures in children with cancer. Pediatrics 1992; 89: 631-4
60. Friedman AG, Mulhern RK, Fairclough D, et al. Midazolam premedication for pediatric bone marrow aspiration and lumbar puncture. Med Pediatr Oncol 1991; 19: 499-504
61. Sheridan RL, McEttrick M, Bacha G, et al. Midazolam infusion in pediatric patients with burns who are undergoing mechanical ventilation. J Burn Care Rehabil 1994; 15: 515-8
62. Rosen DA, Rosen KR. Midazolam for sedation in the paediatric intensive care unit. Intensive Care Med 1991; 17: S15-S19
63. Salonen M, Kanto J, Iisalo E, et al. Midazolam as an induction agent in children: a pharmacokinetic and clinical study. Anesth Analg 1987; 66: 625-8
64. Ilkhanipour K, Juels CR, Langdorf MI. Pediatric pain control and conscious sedation: a survey of emergency medicine residencies. Acad Emerg Med 1994; 1: 368-72
65. Shane SA, Fuchs SM, Khine H. Efficacy of rectal midazolam for the sedation of preschool children undergoing laceration repair. Ann Emerg Med 1994 24: 1065-73
66. Kuman A, Bleck TP. Intravenous midazolam for the treatment of refractory status epilepticus. Crit Care Med 1992; 20: 483-8